Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
01 2019
Historique:
received: 30 10 2017
accepted: 26 06 2018
pubmed: 18 7 2018
medline: 15 5 2020
entrez: 18 7 2018
Statut: ppublish

Résumé

Patients admitted with acute variceal bleeding (AVB) and Child-Pugh C score (CP-C) or Child-Pugh B plus active bleeding at endoscopy (CP-B+AB) are at high risk for treatment failure, rebleeding, and mortality. A preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) has been shown to improve survival in these patients, but its use in clinical practice has been challenged and not routinely incorporated. The present study aimed to further validate the role of preemptive TIPS in a large number of high-risk patients. This multicenter, international, observational study included 671 patients from 34 centers admitted for AVB and high risk of treatment failure. Patients were managed according to current guidelines, and use of drugs and endoscopic therapy (D+E) or p-TIPS was based on individual center policy. p-TIPS in the setting of AVB is associated with a lower mortality in CP-C patients compared with D+E (1 year mortality 22% vs. 47% in D+E group; P = 0.002). Mortality rate in CP-B+AB patients was low, and p-TIPS did not improve it. In CP-C and CP-B+AB patients, p-TIPS reduced treatment failure and rebleeding (1-year cumulative incidence function probability of remaining free of the composite endpoint: 92% vs. 74% in the D+E group; P = 0.017) and development of de novo or worsening of previous ascites without increasing rates of hepatic encephalopathy. Conclusion: p-TIPS must be the treatment of choice in CP-C patients with AVB. Because of the strong benefit in preventing further bleeding and ascites, p-TIPS could be a good treatment strategy for CP-B+AB patients.

Identifiants

pubmed: 30014519
doi: 10.1002/hep.30182
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

282-293

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2018 by the American Association for the Study of Liver Diseases.

Auteurs

Virginia Hernández-Gea (V)

Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi I i Sunyer, IMDIM, University of Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.

Bogdan Procopet (B)

Regional Institute of Gastroenterology and Hepatology "Octavian Fodor", Hepatology Department and "Iuliu Hatieganu" University of Medicine and Pharmacy, 3rd Medical Clinic, Cluj-Napoca, Romania.

Álvaro Giráldez (Á)

Clinical Management Unit of Digestive Diseases, University Hospital Virgen del Rocio, Seville, Spain.

Lucio Amitrano (L)

Gastroenterology Unit, Ospedale A Cardarelli, Naples, Italy.

Candid Villanueva (C)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Servei de Patologia Digestiva, Hospital de la Santa Creu i Sant Pau and CIBERehd, Barcelona, Spain.

Dominique Thabut (D)

Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.

Luis Ibañez-Samaniego (L)

Servicio de Medicina de Aparato Digestivo Gregorio Marañón, Hospital General Universitario Gregorio Marañón, liSGM, CIBERehd, Barcelona, Spain.

Gilberto Silva-Junior (G)

Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi I i Sunyer, IMDIM, University of Barcelona, Barcelona, Spain.

Javier Martinez (J)

Department of Gastroenterology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, CIBERehd, Madrid, Spain.

Joan Genescà (J)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona and CIBERehd, Barcelona, Spain.

Christophe Bureau (C)

Department of Hepato-Gastroenterology, Purpan Hospital, CHU Toulouse, INSERM U858, University of Toulouse, France, Toulouse, France.

Jonel Trebicka (J)

Department of Internal Medicine I, University of Bonn, Bonn, Germany.
European Foundation for the Study of Chronic Liver Failure (EF-Clif), Barcelona, Spain.
Institute for Bioengineering of Catalonia, Barcelona, Spain.
Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.

Elba Llop (E)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Liver Unit, Hospital U, Puerta de Hierro. Universidad Autònoma de Madrid, CIBERehd, Madrid, Spain.

Wim Laleman (W)

Department of Liver and Biliopancreatic Disorders, University of Leuven, Leuven, Belgium.

Jose Maria Palazon (JM)

Hospital General Universitario de Alicante, Alicante, Spain.

Jose Castellote (J)

Gastroenterology Department, Hepatology Unit, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.

Susana Rodrigues (S)

Gastroenterology and Hepatology Department, Centro Hospitalar São João, Porto, Portugal.

Lise L Gluud (LL)

Gastrounit, Medical Division, University Hospital of Hvidovre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Carlos Noronha Ferreira (C)

Serviço de Gastrenterologia e Hepatologia, Hospital de Santa Maria - Centro Hospitalar Lisboa Norte, Lisbon, Portugal.

Rafael Barcelo (R)

Medical Statistics Core Facility, Institut D'Investigacions Biomédiques August Pi i Sunyer, Hospital Clinic Barcelona, Barcelona, Spain.

Nuria Cañete (N)

Liver Section, Gastroenterology Department, Hospital del Mar, Universitat Autònoma de Barcelona, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Manuel Rodríguez (M)

Department of Gastroenterology, Hospital Central de Asturias, Oviedo, Spain.

Arnulf Ferlitsch (A)

Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.

Jose Luis Mundi (JL)

Department of Gastroenterology, University Hospital San Cecilio, Granada, Spain.

Henning Gronbaek (H)

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Manuel Hernández-Guerra (M)

Gastroenterology Department, University Hospital of the Canary Islands, La Laguna, Tenerife, Spain.

Romano Sassatelli (R)

Unit of Gastroenterology and Digestive Endoscopy, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy.

Alessandra Dell'Era (A)

Gastroenterology Unit, ASST Fatebenefratelli Sacco, Department of Clinical and Biomedical Sciences, University of the Studies of Milan, Milan, Italy.

Marco Senzolo (M)

Multivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University Hospital of Padua, Padua, Italy.

Juan G Abraldes (JG)

Cirrhosis Care Clinic, Division of Gastroenterology (Liver Unit), CEGIIR, University of Alberta, Edmonton, Canada.

Manuel Romero-Gómez (M)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Unidad de Hepatología, Hospital Universitario de Valme, CIBERehd, Sevilla, Spain.

Alexander Zipprich (A)

First Department of Internal Medicine, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Meritxell Casas (M)

Hepatology Unit, Digestive Disease Department Hospital de Sabadell, Universitat Autónoma de Barcelona, Sabadell, Spain.

Helena Masnou (H)

Hospital Universitari Germans Trias i Pujol, Universitat Autònoma Barcelona, Badalona, Spain.

Massimo Primignani (M)

Division of Gastroenterology and Hepatology, IRCCS Ca' Granda Maggiore Hospital Foundation, University of Milan, Milan, Italy.

Aleksander Krag (A)

Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.

Frederik Nevens (F)

Department of Liver and Biliopancreatic Disorders, University of Leuven, Leuven, Belgium.

Jose Luis Calleja (JL)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Liver Unit, Hospital U, Puerta de Hierro. Universidad Autònoma de Madrid, CIBERehd, Madrid, Spain.

Christian Jansen (C)

Department of Internal Medicine I, University of Bonn, Bonn, Germany.

Marie Angèle Robic (MA)

Department of Hepato-Gastroenterology, Purpan Hospital, CHU Toulouse, INSERM U858, University of Toulouse, France, Toulouse, France.

Irene Conejo (I)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona and CIBERehd, Barcelona, Spain.

Maria-Vega Catalina (MV)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Servicio de Medicina de Aparato Digestivo Gregorio Marañón, Hospital General Universitario Gregorio Marañón, liSGM, CIBERehd, Barcelona, Spain.

Agustin Albillos (A)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Department of Gastroenterology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, CIBERehd, Madrid, Spain.

Marika Rudler (M)

Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.

Edilmar Alvarado (E)

Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Servei de Patologia Digestiva, Hospital de la Santa Creu i Sant Pau and CIBERehd, Barcelona, Spain.

Maria Anna Guardascione (MA)

Gastroenterology Unit, Ospedale A Cardarelli, Naples, Italy.

Marcel Tantau (M)

Regional Institute of Gastroenterology and Hepatology "Octavian Fodor", Hepatology Department and "Iuliu Hatieganu" University of Medicine and Pharmacy, 3rd Medical Clinic, Cluj-Napoca, Romania.

Jaime Bosch (J)

Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi I i Sunyer, IMDIM, University of Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Swiss Liver Centre, Inselspital, Bern University, Bern, Switzerland.

Ferran Torres (F)

Medical Statistics Core Facility, Institut D'Investigacions Biomédiques August Pi i Sunyer, Hospital Clinic Barcelona, Barcelona, Spain.
Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Juan Carlos Garcia-Pagán (JC)

Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi I i Sunyer, IMDIM, University of Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH